About: Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: $52.17 (+3.70%)
VCYT NASDAQ Veracyte Inc
Veracyte Inc share price
Atividade de preço de VCYT
Último preço
$ 52,170
Variação (24h)
1,86 USD (3,70%)
Volume
1.23M
Volume (média 4 sem.)
-
Abertura
$ 50,82
Variação do dia
$ 49,63 - $ 52,39
Fechamento anterior
$ 50,31
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
VCYT price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals